Business Description
Founded in 2011 and based in Waltham, Massachusetts, Damora Therapeutics Inc. is a drug development company working on new treatments for blood disorders across Denmark and North America. Its main focus is a group of antibody-based medicines designed to target a specific genetic mutation linked to certain blood cancers, with the goal of helping a broad range of patients affected by this condition. The company is also advancing a small molecule drug aimed at treating acute myeloid leukemia.
